Biodesix Inc Strategic Asset Allocation Index
Biodesix Inc strategic asset allocation index. Biodesix Inc (BDSX) has a Strategic Asset Allocation Index of 42.8% as of December 2022. Strategic assets (PP&E of $8.82 Million plus long-term investments of $-) total $8.82 Million, measured against net assets of $20.61 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BDSX equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Biodesix Inc (2020–2022)
Strategic asset allocation index of Biodesix Inc from 2020 to 2022. This chart shows how Biodesix Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 42.8%, representing strategic assets of $8.82 Million against net assets of $20.61 Million USD. Check BDSX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Biodesix Inc Strategic Asset Allocation Index by Year (2020–2022)
Biodesix Inc strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Biodesix Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Biodesix Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.8% | $8.82 Million | $8.82 Million | $- | $20.61 Million | ▲ +21.6 pp |
| 2021 | 21.2% | $4.18 Million | $4.18 Million | $- | $19.73 Million | ▲ +13.5 pp |
| 2020 | 7.7% | $3.18 Million | $3.18 Million | $- | $41.17 Million | — |